The FDA has announced a new approval pathway designed to support the development of drugs for ultra-rare diseases The FDA has announced a new approval pathway designed to support the development of drugs for ultra-rare diseases by Jacqueline Glennon, Aselle Kurmanova, and Danielle Sapega at Cozen O’Connor Read the update March 5, 2026 Morning Brief